NCT01579539View on ClinicalTrials.gov

The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 27, 2013

Primary Completion Date

May 18, 2017

Study Completion Date

May 18, 2017

Conditions
Thyroid-associated OphthalmopathyDry Eye Syndrome
Interventions
DRUG

Methylprednisolone

500mg i.v. infusion once a week for 6 weeks followed by 250mg i.v. infusion once a week for 6 weeks

DRUG

Esomeprazole

40mg i.v. infusion once a week for 12 weeks

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01579539 - The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy | Biotech Hunter | Biotech Hunter